Mistletoe Clinical Studies | ABNOBA India – Advancing Integrative Oncology
Explore mistletoe clinical studies with ABNOBA India. Learn how mistletoe extracts support cancer care by improving quality of life, reducing therapy side effects, and advancing integrative oncology research.

Mistletoe (Viscum album) has been widely studied in Europe for decades, particularly in the field of integrative oncology. As a research-based pharmaceutical manufacturer, ABNOBA GmbH has been at the forefront of producing high-quality mistletoe extracts and supporting scientific research into their therapeutic potential.

The Focus of Clinical Studies

Clinical studies on mistletoe therapy have primarily examined its role in improving the quality of life for cancer patients. Researchers have investigated the effects of mistletoe extracts on:

  • Immune system modulation – stimulating natural killer (NK) cells and T-lymphocytes.

  • Tumor-related symptoms – such as fatigue, appetite loss, and sleep disturbances.

  • Chemotherapy and radiotherapy tolerance – reducing side effects like nausea and boosting overall resilience.

  • Survival outcomes – exploring the potential for extended survival in certain cancer types.

Evidence from Research

Several European studies suggest that mistletoe therapy, when used alongside conventional treatment, may improve well-being, reduce therapy-related side effects, and enhance emotional stability in patients. Ongoing clinical trials continue to explore its role as an adjuvant therapy, assessing not only survival but also patient-reported outcomes such as energy levels, mood, and overall health perception.

ABNOBA’s Contribution

As a medium-sized, research-driven pharmaceutical company based in Pforzheim, Germany, ABNOBA GmbH is dedicated to advancing evidence-based integrative oncology. By investing in high-quality clinical studies, ABNOBA supports physicians and patients in making informed choices about mistletoe therapy.

Conclusion

 

Mistletoe clinical studies highlight its importance as a complementary approach in cancer treatment, focusing on patient-centered outcomes. With continued research and scientific commitment, ABNOBA aims to further establish mistletoe extracts as a trusted option within integrative cancer care.

disclaimer

What's your reaction?